EXTENSIVE PYODERMA GANGRENOSUM IN A PATIENT NONADHERENT TO THE TREATMENT
The growth factor receptor inhibitors represent a relative new class of medications which have been often used on oncology to treat various types of neoplasia. Many tegumentary manifestations have been described. On this article, we report a case of 55 year-old-male in use of sunitinib malate to treat metastatic renal carcinoma that developed hypercromic spots, perlèche and palmar erythema. On this report, we discuss the features of these manifestations and the impact that they have on the patients quality of life.
All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).